Esra KARAMAN, Tuba OZTURK DEMİR, Feride Sinem AKGUN

Efficacy of ProBNP and CRP/ Albumin ratio in patients with acute heart failure in the Emergency Department

AbstractAim: Heart failure (HF) is one of the most common diseases in patients over 65 years of age.It is a clinical condition which is often mortal and requires intensive care follow-up. Therefore, some tests are used to predict the diagnosis, treatment and prognosis. In this study, we aimed to compare the effect of natriuretic peptides (ProBNP) and CRP/albumin ratio on mortality and prognosis in patients who referred to the emergency department (ED) with HF.Material and Methods: The patients with ICD codes of I50 and J81 in two different hospital ED between 2018 and 2019 were analyzed retrospectively. Demographic data of the patients and the parameters planned to be studied were recorded in a Microsoft Excel 2010 file. NCSS (Number Cruncher Statistical System) 2007 software was used for the statistical analysis.Results: Our study consisted of 301 patients. A very weak positive (CRP/albumin ratio increased as the ProBNP value increased) correlation of 0.193 between ProBNP measurements and CRP/albuminratios of the participants was found to be statistically significant(r=0.193; p=0.001; p

PDF

___

1. Nieminen MS, Harjola VP. Definition and epidemiology of acute heart failure syndromes. Am J Cardiol 2005;96:5-10.
2. Gheorghiade M, Mebazaa A. The challenge of acute heart failure syndromes. Am J Cardiol 2005;96:86-9.
3. Maisel AS, McCord J, Nowak RM, et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the breathing not properly multinational study. J Am Coll Cardiol 2003;41:2010-7.
4. Hellenkamp K, Von Haehling S. The relevance of biomarkers in acute heart failure. Der Internist 2019;60:587-96.
5. Matowicka-Karna J. Markers of inflammation, activation of blood platelets and coagulation disorders in inflammatory bowel diseases. Postepy Hig Med Dosw (online) 2016;70:305-12.
6. Kaplan M, Ates I, Akpinar MY, et al. Predictive value of C-reactive protein/albümin ratio in acute pancreatitis. Hepatobiliary Pancreat Dis Int 2017;16:424-30.
7. Karabağ Y, Çağdaş M, Rencuzoğulları I, at al. Usefulness of the C-reactive protein/albumin ratio for predicting no-reflow in st-elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur J Clin Invest 2018;48:12928.
8. Çınar T, Tanık VO, Burak C et al. Prognostic efficacy of C-reactive protein to albumin ratio in patients with st-elevation myocardial infarction complicated by cardiogenic shock. Kocaeli Med J 2019;8:134-41.
9. Park JE, Chung KS, Song JH, et al. The C-reactive protein/albümin ratio as a predictor of mortality in critically III patients. J Clin Med 2018;7:333.
10. Fonarow GC. Epidemiology and risk stratification in acute heart failure. Am Heart J 2008;155:200-7.
11. Fonarow GC, Abraham WT, Albert NM. Influence of a performance improvement initiative on quality of care for patients hospitalized with heart failure: results of the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (optimizeHF). Arch Intern Med 2007;167:1493-502.
12. Martindale JL, Wakai A, Collins SP, et al. Diagnosing acute heart failure in the emergency department: a systematic review and meta-analysis. Academic Emergency Med 2016;23:223-42.
13. 2017 ocak-ekim acil servis verileri. https:// dosyamerkez.saglik.gov.tr/Eklenti/23496,2017-ocakekim-donemi-acil-servis-verileri.
14. Santaguida PL, Don-Wauchope AC, Oremus M, et al. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Failure Reviews 2014;19:453-70.